drugset / Trial / NCT06543290

Azithromycin Before Induction

NCT06543290

Phase 1 Recruiting 400 enrolled Arrowhead Regional Medical Center
RandomizedParallel-groupDouble-blindPrevention

Summary

This is a double blinded randomized control trial involving administration of 2 grams prophylactic azithromycin in third trimester patients undergoing induction of labor at our institution to demonstrate reduction in maternal and neonatal infection.

Timeline

Start
2023-08-07
Primary completion
2026-08-07
Completion
2026-08-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azithromycin Small molecule 2 g Oral

Indications